Relationship between uric acid and arterial stiffness in the elderly with metabolic syndrome components

Chinese Medical Journal

Volumn 126, Issue 16, 2013, Pages 3097-3102

  Sun, Ning ^a   Zhang, Yun ^a   Tian, Jian li ^a   Wang, Hui ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Metabolic syndrome; Pulse wave velocity; Uric acid

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PULSE WAVE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; BRACHIAL ARTERY; CHOLESTEROL, HDL; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; URIC ACID; VASCULAR STIFFNESS;

EID: 84882269172     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20130215     Document Type: Article

References (37)

1. Matsui Y, Kario K, Ishikawa J, Eguchi K, Hoshide S, Shimada K. Reproducibility of arterial stiffness indices (pulse wave velocity and augmentation index) simultaneously assessed by automated pulse wave analysis and their associated risk factors in essential hypertensive patients. Hypertens Res 2004; 27: 851-857.
2. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
3. Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 2009; 61: 225-232.
4. Panero F, Gruden G, Perotto M, Fornengo P, Barutta F, Greco E, et al. Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study. Atherosclerosis 2012; 221: 183-188.
5. Wu YQ, Li J, Xu YX, Wang YL, Luo YY, Hu D Y, et al. Predictive value of serum uric acid on cardiovascular disease and all-cause mortality in urban Chinese patients. Chin Med J 2010; 123: 1387-1391.
6. Zhang Z, Bian L, Choi Y. Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in Korean men. Angiology 2012; 63: 420-428.
7. Chen X, Li Y, Sheng CS, Huang QF, Zheng Y, Wang JG. Association of serum uric acid with aortic stiffness and pressure in a Chinese workplace setting. Am J Hypertens 2010; 23: 387-392.
8. Shin JY, Lee HR, Shim JY. Signifcance of high-normal serum uric acid level as a risk factor for arterial stiffness in healthy Korean men. Vasc Med 2012; 17: 37-43.
9. Lim JH, Kim YK, Kim YS, Na SH, Rhee MY, Lee MM. Relationship between serum uric acid levels, metabolic syndrome, and arterial stiffness in korean. Korean Circ J 2010; 40: 314-320.
10. Tsioufs C, Kyvelou S, Dimitriadis K, Syrseloudis D, Sideris S, Skiadas I, et al. The diverse associations of uric acid with low-grade infammation, adiponectin and arterial stiffness in never-treated hypertensives. J Hum Hypertens 2011; 25: 554-559.
11. Reunanen A, Takkunen H, Knekt P, Aromaa A. Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand Suppl 1982; 668: 49-59.
12. Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolic syndrome in women and men. Metabolism 2008; 57: 845-852.
13. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112: 3066-3072.
14. Nakanishi N, Shiraishi T, Wada M. Brachial-ankle pulse wave velocity and metabolic syndrome in a Japanese population: the Minoh study. Hypertens Res 2005; 28: 125-131.
15. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005; 25:1038-1044.
16. Wang ZW, Wang X, Li X, Chen Z, Zhao LC, Li Y, et al. Prevalence and trend of metabolic syndrome in middle-aged Chinese population. Chin J Epidemiol (Chin) 2009; 30: 596-600.
17. Lin Y, Lai X, Chen G, Xu Y, Huang B, Wu Y, et al. Association among serum uric acid, cardiovascular risk, and arterial stiffness: a cross-sectional study in She ethnic minority group of Fujian Province in China. J Endocrinol Invest 2012; 35: 290-297.
18. Saijo Y, Utsugi M, Yoshioka E, Horikawa N, Sato T, Gong YY, et al. Relationships of C-reactive protein, uric acid, and glomeru-lar fltration rate to arterial stiffness in Japanese subjects. J Hum Hypertens 2005; 19: 907-913.
19. Meisinger C, Koenig W, Baumert J, Doring A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic infammation in men from the general population: the MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol 2008; 28: 1186-1192.
20. Stellato D, Morrone LF, Di Giorgio C, Gesualdo L. Uric acid: a starring role in the intricate scenario of metabolic syndrome with cardio-renal damage? Intern Emerg Med 2012; 7: 5-8.
21. Heinig M, Johnson RJ. Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med 2006; 73: 1059-1064.
22. Li S, Chen W, Srinivasan SR, Berenson GS. Influence of metabolic syndrome on arterial stiffness and its age-related change in young adults: the Bogalusa Heart Study. Atherosclerosis 2005; 180: 349-354.
23. Adams RJ, Appleton S, Wilson DH, Taylor AW, Dal Grande E, Chittleborough C, et al. Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus defnition. Diabetes Care 2005; 28: 2777-2779.
24. Tsubakimoto A, Saito I, Mannami T, Naito Y, Nakamura S, Dohi Y, et al. Impact of metabolic syndrome on brachial-ankle pulse wave velocity in Japanese. Hypertens Res 2006; 29: 29-37.
25. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 2006; 21: 1-6.
26. Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 2005; 56: 45-62.
27. Martinon F. Update on biology: uric acid and the activation of immune and infammatory cells. Curr Rheumatol Rep 2010; 12: 135-141.
28. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, et al. Uric acid stimulates Monocyte Chemoattractant protein-1 production in vascular smooth muscle cells via MITOGEN-activated protein kinase and cyclooxygenase-2. Hypertension 2003; 41: 1287-1293.
29. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007; 293: C584-C596.
30. Baldwin W, McRae S, Marek G, Wymer D, Pannu V, Baylis C, et al. Hyperuricemia as a mediator of the proinfammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes 2011; 60: 1258-1269.
31. Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincon A, et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 2010; 5: 1388-1393.
32. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67: 1739-1742.
33. Tomiyama H, Higashi Y, Takase B, Node K, Sata M, Inoue T, et al. Relationships among hyperuricemia, metabolic syndrome, and endothelial function. Am J Hypertens 2011; 24: 770-774.
34. Kato M, Hisatome I, Tomikura Y, Kotani K, Kinugawa T, Ogino K, et al. Status of endothelial dependent vasodilation in patients with hyperuricemia. Am J Cardiol 2005; 96: 1576-1578.
35. Erdogan D, Gullu H, Caliskan M, Yildirim E, Bilgi M, Ulus T, et al. Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract 2005; 59: 1276-1282.
36. Takeno K, Mita T, Nakayama S, Goto H, Komiya K, Abe H, et al. Masked hypertension, endothelial dysfunction, and arterial stiffness in type 2 diabetes mellitus: a pilot study. Am J Hyper-tens 2012; 25: 165-170.
37. Tsai WC, Huang YY, Lin CC, Li WT, Lee CH, Chen JY, et al. Uric acid is an independent predictor of arterial stiffness in hypertensive patients. Heart Vessels 2009; 24: 371-375.